Purchase Order 75F40122P00493
Award Date 9/21/22
Potential Completion Date 12/31/23
Potential Value $220K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Healthpartners Institute, a non-profit organization, for $148,751.08. The contract is for medical and scientific consulting services with a period of performance through September 26, 2017. The contract does not have a set-aside designation. As a child company, Healthpartners Institute has been awarded federal contracts and grants in the past. The CDC, a civilian agency,...
- The Department of Health and Human Services Food and Drug Administration awarded a definitive contract to the Institute for Safe Medication Practices, a 501(c)(3) nonprofit organization. The $209,738.72 contract, which was not set aside, is for the delivery of a Perioperative Medication Safety Self-Assessment for Hospitals and Ambulatory Surgical Centers (ASCs) and Targeted Risk-Reduction Tool Development. Through past prime federal contracts, the Institute for Safe Medication Practices has...
- This is a federal delivery order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Healthpartners Institute, a non-profit organization. The contract, which has a potential value of $2,465,115.88, is for critical functions related to the Coronavirus COVID-19 national interest action. The contract is a delivery order under the Vaccine Safety Datalink Project master IDIQ contract. The contract does not have a set-aside designation, and the...
- This is a new task order awarded under an existing Indefinite Delivery Indefinite Quantity (IDIQ) contract (HHSF223201610004I) with the Department of Health and Human Services Food and Drug Administration (FDA). The task order, valued at $2,470,791.00, is for a Pharmacokinetic (PK) study of opioid drug products following oral ingestion of chewed products. The study falls under the FDA's In Vivo Study of Generic Drug Products in Human Subjects program. The contract is a Firm Fixed Price...
- This is a firm-fixed-price purchase order awarded by the Agency for Healthcare Research and Quality (AHRQ), a civilian agency within the Department of Health and Human Services, to Vindhya Data Science Inc., a self-certified small disadvantaged, woman-owned business. The $171,212 contract is for a study examining the association between dental services and outcomes in persons with HIV and substance abuse disorder. The contract has no set-aside designation. This research aligns with AHRQ's...
- This is a $88,140 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Medstar Health Research Institute Inc., a non-profit organization, to conduct a study on neural injuries and dysfunctions in patients. The contract has a completion date of September 29, 2025 and does not utilize a set-aside designation. The contract stems from a solicitation posted on May 27, 2020 for the procurement of patients diagnosed with mild or moderate traumatic brain...
- The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a firm fixed-price definitive contract worth $595,345.32 to Mark Herring Associates, Inc., a for-profit organization and Subchapter S Corporation. The contract is for a two-phase project, with Phase One involving the collection, analysis, interpretation, and reporting of qualitative data from approximately 140 individuals who have used prescription opioids and at least one of four other substances. The work...
- This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to HealthPartners Institute, a non-profit organization, for sodium reduction and tobacco cessation policy modeling activities. The contract has a Firm Fixed Price pricing type and a ceiling value of $149,850.00. The contract was awarded on September 28, 2015, with a period of performance ending on June 30, 2017. The contract was not set aside for any specific business category. The place of...
- This is a $1,440,515.00 firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the Department of Health and Human Services Food and Drug Administration to the non-profit Research Triangle Institute (RTI) International. The contract is for "HEALTH CARE PROVIDERS' UNDERSTANDING OF OPIOID ANALGESIC ABUSE DETERRENT FORMULATIONS (ADFS)", which falls under the Major Program Code of "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES". The contract has a...
- The Department of Health and Human Services Food and Drug Administration awarded a $2,877,830 firm fixed price delivery order contract to Biopharma Services USA Inc. for NASAL PHARMACOKINETIC (PK)PHARMACODYNAMIC (PD) STUDIES OF ORAL COMBINATION PRODUCTS CONTAINING OPIOID AGONISTS AND ANTAGONISTS. As a foreign owned, self-certified small disadvantaged business, Biopharma Services USA will conduct the in vivo study of generic drug products in human subjects to fulfill the FDA's major program of...
The Department of Health and Human Services Food and Drug Administration awarded a $219,885.00 purchase order contract to Healthpartners Institute, a non-profit organization, to conduct a study on the association between oral transmucosal pain reduction drugs and dental adverse events using integrated real-world data sources. The contract has a completion date of December 31, 2023 and is a labor hours-based contract. No set-aside designation was used for this award. Healthpartners Institute is a subsidiary of the non-profit hospital and healthcare organization Healthpartners, Inc., which has experience in pharmacoepidemiology research and providing expertise for studies related to medication safety and improving dementia care.
Generated 3/23/24, 4:45 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 7/13/23 | |
| P00001 | Other Administrative Action | $0 | 3/15/23 | |
| Not listed | Not listed | $219.9k | 9/21/22 |